Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
As part of the deal, AstraZeneca is acquiring the exclusive rights to ECC5004, an investigational oral once-daily pill for treating obesity, type 2 diabetes and other cardiometabolic conditions
J.CushmanW
Glucagon-like peptide-1 agonists are a class of medications that mimic the natural GLP-1 hormone to manage type 2 diabetes and obesity
For instance, too much potassium can cause hyperkalaemia, particularly in patients with kidney disease
To ensure safety and efficacy, its essential to work closely with your healthcare provider, who can monitor your progress and adjust your treatment plan as needed
US$ 26.59
US$ 28.01
US$ 27.02
US$ 20.91
US$ 28.37
US$ 27.21
US$ 20.33
US$ 23.42
